B. Metzler seel. Sohn & Co. Holding AG Makes New $2.13 Million Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) during the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 66,028 shares of the company’s stock, valued at approximately $2,129,000.

A number of other hedge funds have also modified their holdings of the business. Janus Henderson Group PLC raised its holdings in Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after buying an additional 2,473,282 shares during the period. Deerfield Management Company L.P. Series C raised its stake in shares of Surgery Partners by 47.7% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock valued at $111,986,000 after acquiring an additional 1,520,484 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Surgery Partners in the 2nd quarter worth approximately $29,288,000. Victory Capital Management Inc. boosted its position in shares of Surgery Partners by 140.4% during the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after purchasing an additional 777,038 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Surgery Partners by 26.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock valued at $66,643,000 after purchasing an additional 589,499 shares during the last quarter.

Surgery Partners Stock Up 3.8 %

Shares of NASDAQ:SGRY opened at $23.36 on Friday. The firm has a 50 day simple moving average of $30.15 and a 200-day simple moving average of $28.40. Surgery Partners, Inc. has a twelve month low of $21.36 and a twelve month high of $36.92. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The company has a market capitalization of $2.97 billion, a PE ratio of -48.67, a P/E/G ratio of 16.71 and a beta of 2.76.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.15 earnings per share. On average, equities analysts predict that Surgery Partners, Inc. will post 0.83 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SGRY has been the topic of a number of research reports. Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Citigroup dropped their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Royal Bank of Canada reduced their price target on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, KeyCorp initiated coverage on shares of Surgery Partners in a report on Friday, October 11th. They issued a “sector weight” rating for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $38.71.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.